GlassScriptPhysician profile
Eddie K Abdalla
NPI 1235225889
$33,647.01
in general payments reported to CMS, 2019-2025
17 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,835 · 2020: $1,875 · 2021: $362 · 2022: $782 · 2023: $21K · 2024: $2,833 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $4,460 · Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,100.00 |
| Travel and Lodging | $4,459.75 |
| Food and Beverage | $2,233.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $27,281.10 | 2019-2025 | Sir-Spheres Microspheres |
| Intuitive Surgical, INC. | $2,719.48 | 2019-2024 | |
| Angiodynamics, INC. | $1,366.57 | 2019-2024 | Nanoknife |
| Boston Scientific Corporation | $633.27 | 2023-2024 | Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Ethicon US, LLC | $449.39 | 2019-2024 | Echelon; Endopath, Surgiflo Hemostatic Matrix |
| Abbvie INC. | $439.74 | 2019-2025 | |
| Medtronic, INC. | $226.50 | 2021-2025 | Gi Genius, Emprint |
| Iovance Biotherapeutics, INC. | $154.45 | 2025 | Amtagvi |
| Advanced Accelerator Applications | $125.23 | 2019 | |
| Baxter Healthcare | $103.23 | 2019-2025 | Tisseel, Perclot, Floseal |
| Integra Lifesciences Corporation | $38.66 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Biom'Up Sa | $23.30 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.22 | 2020 | |
| Prescient Surgical | $20.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.23 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $12.88 | 2021 | |
| Kerecis Limited | $9.95 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddie Abdalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.